Croma-Pharma
Private Company
Funding information not available
Overview
Croma-Pharma is a long-established, private Austrian medtech and aesthetics company with a global footprint. It focuses on minimally invasive treatments in ophthalmology, dermatology, and aesthetics, offering a trusted, single-source portfolio of products like dermal fillers and medical devices. The company leverages a family-owned structure for stability and invests significantly in professional education (cromacare) to drive adoption and loyalty. Its business model is commercial, generating revenue through B2B sales to medical practitioners.
Technology Platform
Expertise in formulation and manufacturing of biocompatible injectables (e.g., hyaluronic acid-based dermal fillers) and ophthalmic medical devices, supported by the integrated cromacare global education platform for practitioners.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Croma-Pharma competes in the crowded global medical aesthetics market against giants like AbbVie (Allergan), Galderma, and Merz Pharma, as well as numerous other specialized companies. Its differentiation relies on its family-owned, practitioner-focused approach, comprehensive product portfolio for core indications, and its dedicated cromacare education system.